Exciting News: FDA Has Approved New Alzheimer's Treatment

President & CEO Update

Alzheimer's Association

This message is sent to all Alzheimer's Association and Alzheimer's
Impact Movement board members, all Alzheimer's Association staff, and
volunteers and supporters of AIM and the Alzheimer's Association.

The Alzheimer's Association welcomes and celebrates
today's historic Food and Drug Administration (FDA) approval of
aducanumab for the treatment of Alzheimer's disease.

While certainly not a cure, this is the first ever FDA-approved
treatment for the underlying biology of Alzheimer's, not just
the symptoms. Slowing progression for those with Mild Cognitive
Impairment (MCI) due to Alzheimer's disease or Alzheimer's
dementia in its earliest stage offers the potential for more precious
time for diagnosed individuals and their loved ones.

This new treatment approval and sustained progress in the research
field benefit from years of investment and relentless dedication to
our vision of a world without Alzheimer's and all other dementia.

The advances the Alzheimer's Association has been able to drive
on behalf of our constituents, to bring us to this historic moment,
are thanks to you and others who have been so supportive. I am deeply
grateful to you for the role you have played to make this day
possible. Thank you!

With your support, the Alzheimer's Association has advanced
research in many ways, including directly funding the tools for early
detection that have facilitated development of new treatments.

Of course, as I'm sure you realize, our work is not done. The
fight to end Alzheimer's is as urgent as ever. As the leader in
the quest to end Alzheimer's and all other dementia, you can be
assured that the Alzheimer's Association will fight to ensure
access to this treatment and ultimately others for all communities. We
won't stop until the day our vision becomes reality for
everyone.

I look forward to sharing more with you as this treatment becomes
available and others advance. I hope you can join us for a special
volunteer meeting on Tuesday, June 8 at 5 p.m. CT. To add the event to
your calendar, click one of these links:
Google Calendar | Outlook/Hotmail Calendar | iCal/Other Calendar

[link removed]

[link removed]

[link removed]

Thank you again, as always, for everything you have done and
everything you continue to do to drive our mission advances and to
make a difference today and tomorrow for so many others.

Sincerely,

Harry Johns Signature

Harry Johns
Chief Executive Officer

If you or a loved one is experiencing memory changes, the
Alzheimer's Association strongly encourages speaking with a
health care provider for a thorough evaluation, diagnosis and to
discuss treatment options.
Visit the Alzheimer's Association at alz.org, or reach our
Helpline 24/7 at 800.272.3900.

CONNECT WITH US

Facebook

Twitter

Pinterest

Blog

[link removed]
[link removed]
[link removed]
[link removed]

Alzheimer's Association

Alzheimer's Association

225 N. Michigan Ave., FL 17, Chicago, IL
60601

800.272.3900 | alz.org

tel:800.272.3900
[link removed]

© 2021 Alzheimer's Association. All rights
reserved. Alzheimer's Association is a not-for-profit 501(c)(3)
organization.

Contact Us
|
Privacy Policy
|
Unsubscribe

[link removed]
[link removed]
[link removed]



To unsubscribe from all future email, paste the following URL into your browser:
[link removed]